Distinctive immunomodulating properties and interactivity with model membranes and cells of two homologous muramyl dipeptide derivatives differing by their lipophilicity

被引:13
作者
Kalyuzhin, OV
Zemlyakov, AE
Fuchs, BB
机构
[1] Lab. of Cell. Immunopathology and B., Institute of Human Morphology, Russian Academy of Medical Sciences, Moscow
来源
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1996年 / 18卷 / 11期
关键词
muramyl dipeptide derivatives; lipophilicity; immunomodulation; biomembranes;
D O I
10.1016/S0192-0561(96)00061-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have studied and compared the immunomodulating activities of two muramyl dipeptide (MDP) derivatives: beta-heptylglycoside-MDP (C(7)H(15)MDP) and beta-hexadecylglycoside-MDP (C(16)H(33)MDP). The amphiphilic derivative C(7)H(15)MDP has been found to be a more effective stimulator of T lymphocyte proliferation and allospecific cytotoxic T cell generation in a mixed lymphocyte culture, and a more effective activator of interleukin-1 (IL-1) and tumour necrosis factor (TNF) production by murine peritoneal macrophages, in comparison with MDP and C(16)H(33)MDP used in equimolar concentrations. C(7)H(15)MDP also stimulated cytotoxicity of natural killer (NK) cells. On the contrary, its lipophilic homologue C(16)H(33)MDP did not show such activities in vitro except for its influence on IL-1 and TNF production. We have found significant differences in the interaction of these two C-14-labelled MDP derivatives with model membranes and in the uptake of these preparations by erythroleukemia K562 cells. We consider the hydrolipophilic balance of the above preparations to be the main cause of their different interactions with membranes and their uptake by cells and, as a result, their opposite immunomodulating activities in vitro. (C) 1997 International Society for Immunopharmacology.
引用
收藏
页码:651 / 659
页数:9
相关论文
共 29 条
[1]  
BAHR GM, 1986, FASEB J, V45, P2541
[2]   ANTIMETASTATIC ACTIVITY OF MDP-L-ALANYL-CHOLESTEROL INCORPORATED INTO VARIOUS TYPES OF NANOCAPSULES [J].
BARRATT, G ;
PUISIEUX, F ;
YU, WP ;
FOUCHER, C ;
FESSI, H ;
DEVISSAGUET, JP .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1994, 16 (5-6) :457-461
[3]  
CERROTINI JC, 1974, J EXP MED, V140, P703
[4]   ROLE OF CORYNEBACTERIUM-PARVUM IN THE ACTIVATION OF PERITONEAL-MACROPHAGES .1. ASSOCIATION BETWEEN INTRACELLULAR C-PARVUM AND CYTO-TOXIC MACROPHAGES [J].
CHAPES, SK ;
HASKILL, S .
CELLULAR IMMUNOLOGY, 1982, 70 (01) :65-75
[5]  
Dozmorov I M, 1991, Biomed Sci, V2, P193
[6]  
FIDLER I J, 1982, Journal of Biological Response Modifiers, V1, P43
[7]  
FIDLER IJ, 1987, J IMMUNOL, V138, P4509
[8]  
FISH H, 1983, INT J CANCER, V32, P105
[9]  
FOGLER WE, 1983, J RETICULOENDOTH SOC, V33, P165
[10]  
FOGLER WE, 1986, J IMMUNOL, V136, P2311